ORX:STO
Orexo AB
SEKÂ 0.88
arrow_upward
+1.27%(+0.011) 1D
Nob 13, 5:29:57 PM GMT+1 · SEK
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ORX...
Buksan
SEKÂ 0.90
Mataas
SEKÂ 0.90
Mababa
SEKÂ 0.83
Mkt. cap
308.06M
Avg. na dami
739.90K
Dami
0.00
P/E ratio
0.06
Mataas nang 52-wk
SEKÂ 22.55
Mababa nang 52-wk
SEKÂ 0.80
EPS
SEKÂ 13.61
Mga natitirang share
35.13M
Bilang ng mga empleyado
55
Buksan
SEKÂ 0.90
Mataas
SEKÂ 0.90
Mababa
SEKÂ 0.83
Mkt. cap
308.06M
Avg. na dami
739.90K
Dami
0.00
P/E ratio
0.06
Mataas nang 52-wk
SEKÂ 22.55
Mababa nang 52-wk
SEKÂ 0.80
EPS
SEKÂ 13.61
Mga natitirang share
35.13M
Bilang ng mga empleyado
55
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TradingView
·
7 oras ang nakalipas
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
3 oras ang nakalipas
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Bloomberg.com
·
12 oras ang nakalipas
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Traders Union
·
7 oras ang nakalipas
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Tungkol sa Orexo AB
CEONikolaj Sørensen
Mga Empleyado55
Itinatag1995
Headquarters-
SektorHealth Care
Industriya-
Websiteorexo.com